Comms Business – Focus Group appoints Daveney as chief strategy and transformation officer
Daveney will work with executive team to define and execute company’s strategy. Focus Group has appointed Jon Daveney as...
Officer
Mintz Welcomes Chris Newman as Chief Marketing & Business Development Officer
Mintz announces that Chris Newman has joined the firm as Chief Marketing & Business Development Officer. With more than two...
Calvetti Ferguson appoints new business development officer
US accounting and advisory practice Calvetti Ferguson has appointed Steve Valenta as a business development officer in its office in...
Ice Miller Welcomes Rebecca Wissler as Chief Marketing & Business Development Officer
Ongoing Leadership Transformation Positions the Firm for Future Success WASHINGTON, May 15, 2025 /PRNewswire/ -- Ice Miller announced today that...
LexisNexis Risk Solutions Names Valentina Isakina as Chief Strategy Officer
ATLANTA, April 8, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions has announced the appointment of Valentina Isakina as its Executive Vice President...
BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leader in AI-driven molecular and immune profiling that accelerates drug development and personalizes patient care, is...
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
WARSAW, Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader,...
International Paper Names Joy Roman as New Chief People & Strategy Officer, Unifying Key Roles
International Paper (NYSE:IP) has appointed Joy Roman as Senior Vice President, Chief People and Strategy Officer, effective February 1. Roman...
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Dr. Secora is formerly the CFO and Executive Leader of Value Translation at RecursionSAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology...
